Cencora, Inc. (COR) Price History:-4.53%(TTM)
Over the latest trailing 12-month period, Cencora, Inc. (COR)'s price cagr is -4.53%. The comparable SPY value is +22.87%. Year-to-date price return is -16.88%. Price CAGR uses adjusted close price history and excludes dividends.
Current Price
$281.67
+$0.19 (+0.07%)
Previous Close: $281.48
Last Session
- Open
- $282.63
- Day High
- $283.84
- Day Low
- $279.62
- Volume
- 1.06M
- Avg Volume
- 1.78M
52-Week Position
28%
of the 52-week price range
- From 52-week high
- -25.39%
- From 52-week low
- +15.05%
52-Week Price Range
52-Week Low
$244.82
May 6, 2026
Current Price
$281.67
28% of range
52-Week High
$377.54
Nov 25, 2025
Price Returns by Period
1 Day
+0.07%
7 Days
+2.41%
30 Days
+7.87%
YTD
-16.88%
1 Year
-4.69%
vs 52W High
-25.39%
COR Price Chart
Long-Term Performance (CAGR)
Price CAGR (3Y)
+16.24%
Price CAGR (5Y)
+18.63%
Total Return CAGR (3Y)
+17.24%
Total Return CAGR (5Y)
+19.86%
CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.
Key Price Statistics
| Current Price | $281.67 |
| Previous Close | $281.48 |
| Day Range | $279.62 - $283.84 |
| 52-Week Range | $244.82 - $377.54 |
| Volume | 1.06M |
| Average Volume | 1.78M |
| Market Cap | $54.80B |
| % from 52W High | -25.39% |
Related Metrics
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch